Article
Differential Regulation of IL-8 by IL-1β and TNFα in Hyaline Membrane Disease
University of Southern California Medical Center
Journal of Clinical Immunology (impact factor:
3.08).
12/1997;
18(1):71-80.
DOI:10.1023/A:1023244005765
pp.71-80
-
Citations (0)
- Cited In (1)
-
Article: Inhaled corticosteroid therapy reduces cytokine levels in sputum from very preterm infants with chronic lung disease.
[show abstract] [hide abstract]
ABSTRACT: To evaluate the effects of inhaled corticosteroid therapy and high-frequency oscillatory ventilation (oscillation) on preterm infants with chronic lung disease (CLD). Ten infants with CLD who received inhaled corticosteroid therapy were enrolled. Week 1 was defined as the first week of therapy. The concentrations of interleukin (IL)-8, tumour necrosis factor-alpha (TNF-alpha), IL-1beta, IL-6, IL-10 and IL-12p70 in serial sputum specimens from the infants were determined using a cytometric bead array. The sputum concentrations of IL-8 obtained from the infants during week 3-4 were significantly lower than those obtained before therapy and during week 1-2. The sputum concentrations of TNF-alpha, IL-6 and IL-10 during week 3-4 were significantly lower than the concentrations during week 1-2. The ratio of IL-8 levels during week 1-2 to those before therapy in infants who received oscillation (n = 4) was significantly lower than in those who received intermittent mandatory ventilation (n = 6). Inhaled corticosteroids may be associated with a decrease in pro-inflammatory cytokine levels in sputum from infants with CLD from 2 weeks after the start of therapy. Our further investigations suggest that therapy with oscillation modulated airway inflammation earlier than therapy with intermittent mandatory ventilation.Acta Paediatrica 02/2009; 98(1):118-22. · 2.07 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
15% maximum inhibition
28-day period
40% maximum inhibition
anti-IL-l antibody
anti-TNF antibodies
Bronchoalveolar lavage cell cytokine relationships
chemokine IL-8
exogenous anti-IL-1 antibody
exogenous anti-TNF antibodies
hyaline membrane disease
IL-8 cell cytokine pathway
IL-8 expression
IL-8 production
IL-l protein levels correlated
lung inflammatory cells
preterm newborns
regulate cytokine-mediated inflammation
regulate production
Sequential bronchoalveolar lavage samples
short-term culture system